Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Adriamycin
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)P3BBB (74)
Adriamycin
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)P3BBB (74)
Adriamycin
Prostate Cancer
University of California, San FranciscoP3BBB (74)
Adriamycin
Fallopian Tube Carcinoma
Brigham and Women's HospitalP3BBB (74)
Adriamycin
Richter Transformation
SWOG Cancer Research NetworkP3BBB (74)
Adriamycin
Soft Tissue Sarcoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P3BBB (74)
Adriamycin
Splenic Marginal Zone Lymphoma
SWOG Cancer Research NetworkP3BBB (74)
Alemtuzumab
Sickle Cell Disease
St. Jude Children's Research HospitalP3BBB (74)
Anamorelin
Non-Small Cell Lung Carcinoma
Helsinn Healthcare SAP3BBB (74)
Balstilimab
Colorectal Cancer
National Cancer Institute (NCI)P3BBB (74)
Bendamustine
Marginal Zone Lymphoma
Henan Cancer HospitalP3BBB (74)
Bortezomib
Acute Myeloid Leukemia
Masonic Cancer Center, University of MinnesotaP3BBB (74)
Bortezomib
Mantle Cell Lymphoma
Ruijin HospitalP3BBB (74)
Bortezomib
Non-Hodgkin Lymphoma
OHSU Knight Cancer InstituteP3BBB (74)
Bortezomib
Neoplasm
Hellenic Society of HematologyP3BBB (74)
Cagrilintide
Obesity Disorder
Novo Nordisk A/SP3BBB (74)
Camustine
Breast Cancer
General Oncology, Inc.P3BBB (74)
Capecitabine
Pancreatic Neoplasm
Tianjin Medical University Cancer Institute and HospitalP3BBB (74)
Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-Hydroxy-4-Methylpentyl)Butanedioate (Ester)
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineP3BBB (74)
Ceritinib
Non-Small Cell Lung Carcinoma
PfizerP3BBB (74)
Cis-Diamminedichloroplatinum Ii
Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP3BBB (74)
Cis-Diamminedichloroplatinum Ii
Head And Neck Squamous Cell Carcinoma
AkesoP3BBB (74)
Cis-Diamminedichloroplatinum Ii
Colorectal Cancer
Tianjin Medical University Cancer Institute and HospitalP3BBB (74)
Cis-Diamminedichloroplatinum Ii
Endometrial Cancer
Eli Lilly and CompanyP3BBB (74)
Cis-Diamminedichloroplatinum Ii
Estrogen-Receptor Negative Breast Cancer
University of WashingtonP3BBB (74)
Showing 1851 to 1875 of 42,289 assets
PreviousPage 75 of 1692Next